Antibiotic Developments
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
Antimicrobial resistance a leading cause of global deaths, study shows
Antimicrobial resistance (AMR) has been found to be a leading cause of death worldwide in a study published in The Lancet. Read more
20 Jan 2022
BioVersys receives funding to develop new class of antibiotics to treat multidrug-resistant bacterial infections
Switzerland-based pharmaceutical company BioVersys has been awarded up to $4.35 million in funding to develop a new class of antibiotics for its work in developing a new class of antibiotics. Read more
7 Jun 2021
Current pipeline for antibiotics insufficient in tackling drug resistance
The current pipeline for antibiotics is insufficient in addressing drug resistance in the world’s most dangerous bacteria, a new report by the World Health Organisation has revealed. Read more
21 Apr 2021
Antibiotic Research UK launches £200K grants programme
Antibiotic Research UK (ANTRUK) has launched a small research grants programme worth up to £200,000, for researchers working on projects tackling antibiotic resistance. Read more
14 Apr 2021
Novo Holdings launches new funding round for AMR projects
The next proposal round of the Novo Holdings REPAIR Impact Fund is now open for life science companies developing new treatments to combat antimicrobial resistance (AMR). Read more
29 Mar 2021
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry. Read more
7 Oct 2021
Sponsored Content
Croda announces new Pharma business
Croda has announced that its Health Care division will now become CrodaPharma, bringing its excipient portfolio together with the recent acquisition, Avanti Polar Lipids and its Adjuvant Systems arm, all under one business. Read more
29 Jun 2022
INTEGRA solutions helping to support RNA sequencing capacity
INTEGRA Biosciences’ electronic handheld pipetting solutions are helping to improve the throughput capacity of bulk RNA barcoding and sequencing (BRB-seq) at Alithea Genomics in Switzerland. Read more
29 Jun 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Charnwood Campus launches NHS and Academia Collaboration Platform
Business leaders, entrepreneurs, innovators and stakeholders gathered at Charnwood Campus to hear about new ways to encourage innovation and accelerate new product development in collaboration with the NHS and academia. Read more
28 Jun 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
CHARM launches AI drug discovery technology with $50M Series A financing
CHARM Therapeutics, a 3D deep-learning research company discovering and developing medicines, announces a $50M Series A financing co-led by F-Prime Capital and OrbiMed for DragonFold AI technology. Read more
28 Jun 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Genomics England to anchor Canary Wharf life science cluster
Genomics England Limited will move its headquarters to Canary Wharf this autumn, as part of the development of a major life science cluster. Read more
27 Jun 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Award winners of sustainable pharma packaging to be announced
YewMaker and Connect in Pharma announce that the winners of the new Sustainable Medicines Packaging Awards will be announced at an in-person champagne ceremony at the Connect In Pharma event in Geneva on 14 September 2022. Read more
27 Jun 2022
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
White Papers
Sponsored Content
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
GEKA Healthcare
GEKA HEALTHCARE creates innovative solutions for extremely precise and hygienic application systems Read more
